Alicia Goodman - Cerus Chief Officer

Cerus Management Efficiency

The company has return on total asset (ROA) of (0.0373) % which means that it has lost $0.0373 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3831) %, meaning that it created substantial loss on money invested by shareholders. Cerus' management efficiency ratios could be used to measure how well Cerus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.2 in 2024. Return On Capital Employed is likely to drop to -0.24 in 2024. At this time, Cerus' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 34.3 M in 2024, whereas Total Current Assets are likely to drop slightly above 99.5 M in 2024.

Similar Executives

Cerus Corporation operates as a biomedical products company. The company was incorporated in 1991 and is headquartered in Concord, California. Cerus Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 631 people. Cerus (CERS) is traded on NASDAQ Exchange in USA. It is located in 1220 Concord Avenue, Concord, CA, United States, 94520 and employs 625 people. Cerus is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Cerus Leadership Team

Cerus Stock Performance Indicators

Additional Tools for Cerus Stock Analysis